Systemic endothelial cell markers in primary antiphospholipid syndrome

Thrombosis and Haemostasis

Volumn 84, Issue 5, 2000, Pages 742-746

  Williams, F M K ^a   Parmar, K ^a   Hughes, G R V ^a   Hunt, B J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiphospholipid syndrome; Endothelium

Indexed keywords

ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PADGEM PROTEIN; PHOSPHOLIPID ANTIBODY; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOSIS; UMBILICAL VEIN;

EID: 0033694198     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614108     Document Type: Article

References (35)

1. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies
2. Antiphospholipid antibodies and thrombosis
3. Endothelial cell activation
4. Haemostasis and the systemic inflammatory response
5. Endothelial cells as target for antiphospholipid antibodies
6. Activation of cultured vascular endothelial cells by antiphospholipid antibodies
7. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo
8. Endothelial cells in physiology and pathophysiology of vascular disorders
9. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
10. Thrombosis in primary antiphospholipid syndrome
11. Antiphospholipid syndrome patients' monocytes are 'primed' to express tissue factor
12. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome
13. Plasma tissue factor reflects endothelial cell injury rather than upregulation of tissue factor expression
14. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
15. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: Marked difference between Wegener's granulomatosis and systemic lupus erythematosus
16. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
17. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
18. Criteria for the diagnosis of lupus anticoagulants: An update
19. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
20. The Taipan snake venom time: A new test for lupus anticoagulant
21. Factor VIII related antigen: An improved enzyme immunoassay
22. Normal expression of cell adhesion molecules in placentae from women with systemic lupus erythematosus and the antiphospholipid syndrome
23. Endothelial cell activation in cutaneous vasculitis
24. Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarction
25. The NFkB and IkB proteins: New discoveries and insights
26. The management of thrombosis in the antiphospholipid-antibody syndrome
27. Platelet activation and turnover in the primary antiphospholipid syndrome
28. Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant
29. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation
30. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I
31. Arterial disease and thrombosis in the antiphospholipid syndrome: A pathogenic role for endothelin 1
32. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
33. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody
34. Large vessel occlusion and gangrene in systemic lupus erythematosus and 'lupus-like' disease. A report of six cases
35. Vascular endothelial growth factor is a secreted angiogenic mitogen